Understanding Lifecore Biomedical Inc. (LFCR)’s financial health through ratios

Lifecore Biomedical Inc. (NASDAQ: LFCR) closed the day trading at $8.36 up 3.85% from the previous closing price of $8.05. In other words, the price has increased by $+0.31 from its previous closing price. On the day, 1455255 shares were traded. LFCR stock price reached its highest trading level at $8.65 during the session, while it also had its lowest trading level at $7.38.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.



For a better understanding of LFCR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.30 and its Current Ratio is at 0.60. In the meantime, Its Debt-to-Equity ratio is 1.98 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 25 when WYNNEFIELD PARTNERS SMALL CAP bought 345,260 shares for $7.97 per share. The transaction valued at 2,751,722 led to the insider holds 1,972,853 shares of the business.

WYNNEFIELD PARTNERS SMALL CAP bought 282,486 shares of LFCR for $2,251,413 on Nov 25. The 10% Owner now owns 2,438,180 shares after completing the transaction at $7.97 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFCR now has a Market Capitalization of 114.61M and an Enterprise Value of 268.74M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.29 while its Price-to-Book (P/B) ratio in mrq is 3.34. Its current Enterprise Value per Revenue stands at 1.47 whereas that against EBITDA is -7.05.

Stock Price History:

Over the past 52 weeks, LFCR has reached a high of $11.95, while it has fallen to a 52-week low of $1.52. The 50-Day Moving Average of the stock is 4.21, while the 200-Day Moving Average is calculated to be 7.07.

Shares Statistics:

Over the past 3-months, LFCR traded about 1.16M shares per day on average, while over the past 10 days, LFCR traded about 1.87M shares per day. A total of 29.63M shares are outstanding, with a floating share count of 29.04M. Insiders hold about 0.20% of the company’s shares, while institutions hold 88.60% stake in the company. Shares short for LFCR as of May 14, 2023 were 1.6M with a Short Ratio of 1.64M, compared to 1.47M on Apr 13, 2023. Therefore, it implies a Short% of Shares Outstanding of 5.27% and a Short% of Float of 6.04%.

Earnings Estimates

Current recommendations for the stock of the company come from 1 analysts. On average, analysts expect EPS of -$0.13 for the current quarter, with a high estimate of -$0.13 and a low estimate of -$0.13, while EPS last year was -$0.08. The consensus estimate for the next quarter is $0.07, with high estimates of $0.07 and low estimates of $0.07.

Analysts are recommending an EPS of between -$0.74 and -$0.74 for the fiscal current year, implying an average EPS of -$0.74. EPS for the following year is -$0.03, with 1 analysts recommending between -$0.03 and -$0.03.

Revenue Estimates

2 analysts predict $28M in revenue for the current quarter. It ranges from a high estimate of $29M to a low estimate of $27M. As of the current estimate, Lifecore Biomedical Inc.’s year-ago sales were $53.07M, an estimated decrease of -47.20% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $38.26M, a decrease of -19.70% over than the figure of -$47.20% in the same quarter last year. There is a high estimate of $38.4M for the next quarter, whereas the lowest estimate is $38.13M.

A total of 1 analysts have provided revenue estimates for LFCR’s current fiscal year. The highest revenue estimate was $200.48M, while the lowest revenue estimate was $200.48M, resulting in an average revenue estimate of $200.48M. In the same quarter a year ago, actual revenue was $185.79M, up 7.90% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $124.49M in the next fiscal year. The high estimate is $124.9M and the low estimate is $124.07M. The average revenue growth estimate for next year is down -37.90% from the average revenue estimate for this year.